DrugPatentWatch Database Preview
Hetero Labs Ltd Iii Company Profile
» See Plans and Pricing
What is the competitive landscape for HETERO LABS LTD III, and what generic and branded alternatives to HETERO LABS LTD III drugs are available?
HETERO LABS LTD III has forty-nine approved drugs.
There are six tentative approvals on HETERO LABS LTD III drugs.
Summary for Hetero Labs Ltd Iii
| US Patents: | 0 |
| Tradenames: | 39 |
| Ingredients: | 38 |
| NDAs: | 49 |
Drugs and US Patents for Hetero Labs Ltd Iii
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hetero Labs Ltd Iii | TORSEMIDE | torsemide | TABLET;ORAL | 079234-001 | Jan 27, 2009 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Hetero Labs Ltd Iii | FINASTERIDE | finasteride | TABLET;ORAL | 090061-001 | Jun 7, 2010 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Hetero Labs Ltd Iii | INDOMETHACIN | indomethacin | CAPSULE, EXTENDED RELEASE;ORAL | 201807-001 | Sep 28, 2012 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Hetero Labs Ltd Iii | LITHIUM CARBONATE | lithium carbonate | CAPSULE;ORAL | 090702-001 | Sep 25, 2009 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Hetero Labs Ltd Iii | TADALAFIL | tadalafil | TABLET;ORAL | 209907-001 | Feb 5, 2019 | AB2 | RX | No | No | Start Trial | Start Trial | ||||
| Hetero Labs Ltd Iii | SIMVASTATIN | simvastatin | TABLET;ORAL | 200895-001 | Nov 25, 2014 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Hetero Labs Ltd Iii | HYDRALAZINE HYDROCHLORIDE | hydralazine hydrochloride | TABLET;ORAL | 040901-002 | Sep 12, 2008 | AA | RX | No | No | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Paragraph IV (Patent) Challenges for HETERO LABS LTD III drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Delayed-release Tablets | 20 mg | ➤ Subscribe | 2015-06-03 |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
